Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Brain Neoplasms 4Ototoxicity 1Neurocognitive Disorders 1Neoplasms 1Neoplasm Metastasis 1Meningioma 1Head and Neck Neoplasms 1Cognitive/Functional Effects 1Cognitive Dysfunction 1Central Nervous System Neoplasms 1Central Nervous System Carcinoma 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Paclitaxel 2Doxorubicin 2Cyclophosphamide 2pegfilgrastim 1exemestane 1Trastuzumab 1Taxes 1Tamoxifen 1Psychiatric Rehabilitation 1Mental Status and Dementia Tests 1Leuprolide 1Letrozole 1Immunotherapy 1Goserelin 1Everolimus 1Docetaxel 1Carboplatin 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Breast Neoplasms, Male × Mental Status and Dementia Tests × Clear all
NCT00609791 2026-06-04

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer

City of Hope Medical Center

Phase 2 Active not recruiting
40 enrolled 16 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡